About Us
Company
Headquartered in Luxembourg, our mission is to advance non-invasive therapeutic solutions by leveraging the scientifically proven benefits of high-altitude (hypoxic) exposure. Through cutting-edge medical devices and personalized software algorithms, we deliver innovative Intermittent Hypoxic Treatments that improve health outcomes and enhance quality of life.
We are proud to be the original pioneers who commercialized the concept of short-term hypoxia adaptation for clinical practice. By harnessing the body’s natural physiological processes, we’ve set a new standard for innovative treatment approaches.
ReOxy® Revolutionizing
Breathing Therapy
In 2014, we launched ReOxy®, an innovative medical device designed for Intermittent Hypoxic Hyperoxic Treatments (IHHT®). Powered by SRT® (Self-Regulated Treatment) technology, ReOxy® offers precise, feedback-driven therapy to optimize patient outcomes. Following the success of ReOxy®, we are expanding its reach into new markets, bringing transformative benefits to patients, healthcare providers, and industries worldwide.
Our Commitment to Innovation
Since 2013, AiMediq has led advancements in medical technology through focused research and development efforts
Scientific Research
Exploring the effects of short-term, tailored hypoxic exposure on health and recovery in both healthy individuals and patients.
Demonstrating the efficacy of IHHT in managing cardiovascular, pulmonary, cerebrovascular, and metabolic conditions.
Feasibility Studies
Establishing IHHT and SRT as effective, patient-friendly alternatives to traditional exercise-based cardiac rehabilitation.
Product Development
Designing and prototyping state-of-the-art medical devices to meet evolving healthcare needs.
With innovation, collaboration, and a passion for improving lives,
AiMediq continues to push the boundaries of medical technology.
ReOxy® is the only device of it’s kind
with clinically proven benefits.
Reach out to us or discover more.